Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

HER2-positive Gastric Cancer × Paclitaxel × 30 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 35 Breast Neoplasms 25 Ovarian Neoplasms 14 Lung Neoplasms 14 Parkinson Disease 4, Autosomal Dominant Lewy Body 12 Triple Negative Breast Neoplasms 11 Endometrial Neoplasms 11 Fallopian Tube Neoplasms 10 Neoplasm Metastasis 9 Squamous Cell Carcinoma of Head and Neck 8 Neoplasms 8 Colorectal Neoplasms 6 Carcinoma 6 Esophageal Squamous Cell Carcinoma 5 Esophageal Neoplasms 5 Urinary Bladder Neoplasms 4 Stomach Neoplasms 4 Small Cell Lung Carcinoma 4 Head and Neck Neoplasms 4 Uterine Cervical Neoplasms 3 Carcinoma, Transitional Cell 3 Carcinoma, Ovarian Epithelial 3 Adenocarcinoma Of Esophagus 3 Uterine Neoplasms 2 Rectal Neoplasms 2 Pathologic Complete Response 2 Oropharyngeal Neoplasms 2 Mouth Neoplasms 2 Melanoma 2 Laryngeal Neoplasms 2

Interventions

trastuzumab deruxtecan 1 pembrolizumab 1 Trastuzumab 1 Oxaliplatin 1 Fluorouracil 1 Cisplatin 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡